eMedicine Specialties > Ophthalmology > Cornea

Dystrophy, Fuchs Endothelial: Differential Diagnoses & Workup

Author: Daljit Singh, MBBS, MS, DSc, Professor Emeritis, Department of Ophthalmology, Guru Nanak Dev University, Amritsar, India; Director, Daljit Singh Eye Hospital
Coauthor(s): Ravijit Singh, MD, Consulting Staff, Department of Ophthalmology, Daljit Singh Eye Hospital
Contributor Information and Disclosures

Updated: Feb 2, 2007

Differential Diagnoses

Corneal Edema, Postoperative
Corneal Erosion, Recurrent
Keratopathy, Pseudophakic Bullous

Other Problems to Be Considered

Aphakic bullous keratopathy
Hassall-Henle warts
Pseudoguttae (secondary to trauma, infection, or toxins)
Disciform keratitis
Chandler syndrome
Congenital hereditary endothelial dystrophy

Workup

Other Tests

  • Perform specular endothelial microscopy examinations of the affected and the unaffected siblings. The photographs of the affected corneas may be kept for future reference. Endothelial cell density, hexagonality, and polymegethism may be recorded. The following 5 stages may be seen, as described by Laing et al:
    • Stage 1: The guttate excrescences are in the form of dark structures with sharply defined single bright spots at their center. The structures are considerably smaller in size than a single endothelial cell. Such an excrescence does not lie near the boundary wall of the cell.
    • Stage 2: The excrescence is almost the size of the endothelial cell. The surrounding cells have a stretched appearance.
    • Stage 3: The excrescence is considerably larger, and many cells are involved in one lesion. The dark structure is 5-10 times the size of an endothelial cell. The adjacent cells are abnormal and have missing boundaries. Many lesions are seen close to each other, but they do not coalesce. The excrescences are of 2 types, a smooth round shape or a rough excrescence.
    • Stage 4: The individual excrescences have coalesced. The net result is multilobed, rather than a round outline. The dark areas have many bright spots. The multilobulated structures cover considerable area. The cells between the excrescence masses tend to become abnormal. Coalesced areas contain both the smooth and the rough variety of excrescences.
    • Stage 5: An organized mosaic of endothelial cells is difficult to see. Many stages may be observed in the different areas of the same eye.
  • Pachymetry is a good way of gauging the increase in corneal edema. The thickness can be compared with the new readings on subsequent visits. Increasing thickness of the cornea means increasing corneal endothelial decompensation. Presence of Descemet folds, epithelial bedewing, and corneal thickness of greater than 0.62 mm indicates potential decompensation.

Histologic Findings

In the early stages, the focal thickening of the Descemet membrane is similar to those seen in the Hassall-Henle warts of the peripheral cornea. The corneal endothelium appears stretched and thinned over the dome of the excrescences.

In advanced cases, a generalized thickening of the Descemet membrane is observed. This thickening appears to bury the cornea guttata that formed in the earlier stages.

In normal corneas, histologic preparations show lamellar separation as an artifact. In the cases of corneal edema, the artifactitious lamellar separation of the lamellae is reduced. Subepithelial bullae formation is seen at the anterior corneal surface. In the periphery of the cornea, subepithelial fibrous tissue is usually seen. Intraepithelial cysts filled with cellular debris are also seen. Intraepithelial basement membrane formation may occur due to the misdirection of the epithelial cells. The Bowman membrane is normal, unless it has been involved in ulcer formation and keratitis, after the rupture of a bulla.

More on Dystrophy, Fuchs Endothelial

Overview: Dystrophy, Fuchs Endothelial
Differential Diagnoses & Workup: Dystrophy, Fuchs Endothelial
Treatment & Medication: Dystrophy, Fuchs Endothelial
Follow-up: Dystrophy, Fuchs Endothelial
Multimedia: Dystrophy, Fuchs Endothelial
References

References

  1. Brady SE, Rapuano CJ, Arentsen JJ, et al. Clinical indications for and procedures associated with penetrating keratoplasty, 1983-1988. Am J Ophthalmol. Aug 15 1989;108(2):118-22. [Medline].

  2. Laing RA, Leibowitz HM, Oak SS, et al. Endothelial mosaic in Fuchs'' dystrophy. A qualitative evaluation with the specular microscope. Arch Ophthalmol. Jan 1981;99(1):80-3. [Medline].

  3. Lorenzetti DW, Uotila MH, Parikh N, Kaufman HE. Central cornea guttata. Incidence in the general population. Am J Ophthalmol. Dec 1967;64(6):1155-8. [Medline].

  4. Melles GR, Remeijer L, Geerards AJ, Beekhuis WH. The future of lamellar keratoplasty. Curr Opin Ophthalmol. Aug 1999;10(4):253-9. [Medline].

  5. Rodrigues MM, Krachmer JH, Hackett J, et al. Fuchs'' corneal dystrophy. A clinicopathologic study of the variation in corneal edema. Ophthalmology. Jun 1986;93(6):789-96. [Medline].

Further Reading

Keywords

Fuchs endothelial dystrophy, Fuchs endothelial dystrophy of the cornea, combined dystrophy of Fuchs, endothelial dystrophy of the cornea, epithelial dystrophy of Fuchs, Fuchs epithelial endothelial dystrophy, late hereditary endothelial dystrophy

Contributor Information and Disclosures

Author

Daljit Singh, MBBS, MS, DSc, Professor Emeritis, Department of Ophthalmology, Guru Nanak Dev University, Amritsar, India; Director, Daljit Singh Eye Hospital
Daljit Singh, MBBS, MS, DSc is a member of the following medical societies: All India Ophthalmological Society, American Society of Cataract and Refractive Surgery, Indian Medical Association, International Intraocular Implant Club, and Intraocular Implant and Refractive Society, India
Disclosure: Nothing to disclose.

Coauthor(s)

Ravijit Singh, MD, Consulting Staff, Department of Ophthalmology, Daljit Singh Eye Hospital
Disclosure: Nothing to disclose.

Medical Editor

Fernando H Murillo-Lopez, MD, Senior Surgeon, Unidad Privada de Oftalmologia CEMES
Fernando H Murillo-Lopez, MD is a member of the following medical societies: American Academy of Ophthalmology
Disclosure: Nothing to disclose.

Pharmacy Editor

Simon K Law, MD, PharmD, Assistant Professor of Ophthalmology, Jules Stein Eye Institute; Chief of Section of Ophthalmology Surgical Services, Department of Veterans Affairs Healthcare Center, West Los Angeles
Simon K Law, MD, PharmD is a member of the following medical societies: American Academy of Ophthalmology, American Glaucoma Society, and Association for Research in Vision and Ophthalmology
Disclosure: Nothing to disclose.

Managing Editor

Christopher J Rapuano, MD, Professor, Department of Ophthalmology, Jefferson Medical College; Co-Chairman of the Cornea Service, Co-Chairman of Refractive Surgery Department, Wills Eye Hospital
Christopher J Rapuano, MD is a member of the following medical societies: American Academy of Ophthalmology, American Society of Cataract and Refractive Surgery, Eye Bank Association of America, Pennsylvania Medical Society, and Philadelphia County Medical Society
Disclosure: Allergan Honoraria Speaking and teaching; Allergan Consulting fee Consulting; Alcon Honoraria Speaking and teaching; Inspire Honoraria Speaking and teaching; RPS Ownership interest Other

CME Editor

Lance L Brown, OD, MD, Ophthalmologist, Affiliated With Freeman Hospital and St John's Hospital, Regional Eye Center, Joplin, Missouri
Disclosure: Nothing to disclose.

Chief Editor

Hampton Roy Sr, MD, Associate Clinical Professor, Department of Ophthalmology, University of Arkansas for Medical Sciences
Hampton Roy Sr, MD is a member of the following medical societies: American Academy of Ophthalmology, American College of Surgeons, and Pan-American Association of Ophthalmology
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.